Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300068693Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial in Intestinal disease comparing Ciprofol group with Propofol group (2 arms). Primary endpoint: Discharge time. Planned start Mar 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300068693.